Revance Therapeutics, a biotechnology company specializing in aesthetic and therapeutic innovations, acquired and rebranded HintMD as OPUL, a fintech platform designed for aesthetic practices. After the acquisition, OPUL introduced a new concept, "Relational Commerce", to strengthen connections between aesthetic practices and their customers.